NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Virus Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Virus Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Herpes Zoster Virus Therapy



Reports from Mie University, Department of Dermatology advance knowledge in herpes zoster virus therapy



August 14th, 2007

New investigation results, "The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster," are detailed in a study published in International Journal of Clinical Practice. "We have analysed zoster-associated pain treated with valaciclovir (VCV) in immunocompetent patients with acute herpes zoster over 6 months, and evaluated the safety of VCV. We know of no reports that evaluate postherpetic neuralgia (PHN) treated with VCV for 6 months," researchers in Tsu, Japan report.

"Predisposing factors that influence PHN were age (over 60 years), clustered vesicles, severity of eruption, sleep disturbance, and...


Source: Virus Weekly (2007-08-14)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login